Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
133 participants
OBSERVATIONAL
2018-02-19
2020-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fed with an enteral product that does not contain partially hydrolyzed protein and medium chain triglycerides and decided to be switched to an enteral product contains partially hydrolyzed protein and medium chain triglycerides as a result of clinical symptoms/diagnosis of gastrointestinal intolerance
* Fed by tube, using enteral tube feeding as sole source of nutrition
* A signed and dated informed consent by subject's legally acceptable representative
Exclusion Criteria
* Intestinal obstruction
* Dialysis treatment
* Requirement of artificial ventilation
* Requirement of parenteral nutrition
* Normal nutrition in addition to enteral tube feeding
* Allergy or intolerance to any ingredient of the study product
* Currently participating in another clinical or non-clinical study
1 Year
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aysugül Alptekin, MD
Role: STUDY_CHAIR
Abbott Turkey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Çukurova University Medical Faculty
Adana, , Turkey (Türkiye)
Hacettepe Üniversitesi University Medical Faculty
Ankara, , Turkey (Türkiye)
Ankara Dışkapı Child Disease Hospital
Ankara, , Turkey (Türkiye)
Gazi University Medical Faculty
Ankara, , Turkey (Türkiye)
Ankara University Medical Faculty
Ankara, , Turkey (Türkiye)
Bursa Yüksek İhtisas Research and Training Hospital
Bursa, , Turkey (Türkiye)
Pamukkale Üniversitesi University Medical Faculty
Denizli, , Turkey (Türkiye)
Elazığ University Medical Faculty
Elâzığ, , Turkey (Türkiye)
Eskişehir Osmangazi University Medical Faculty
Eskişehir, , Turkey (Türkiye)
Koç University Medical Faculty
Istanbul, , Turkey (Türkiye)
İstanbul Kanuni Sultan Süleyman Research and Training Hospital
Istanbul, , Turkey (Türkiye)
İstanbul Şişli Hamidiye Etfal Research and Training Hospital
Istanbul, , Turkey (Türkiye)
İstanbul Ümraniye Research and Training Hospital
Istanbul, , Turkey (Türkiye)
İzmir Behçet Uz Child Disease Hospital
Izmir, , Turkey (Türkiye)
Kocaeli Üniversitesi University Medical Faculty
Kocaeli, , Turkey (Türkiye)
Kırıkkale University Medical Faculty
Kırıkkale, , Turkey (Türkiye)
İnönü Üniversitesi University Medical Faculty
Malatya, , Turkey (Türkiye)
Ondokuz Mayıs University Medical Faculty
Samsun, , Turkey (Türkiye)
Karadeniz Teknik University Medical Faculty
Trabzon, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DA15
Identifier Type: -
Identifier Source: org_study_id